The call highlighted Mosaic's resilience in recovering quickly from natural disasters, achieving strong performance in phosphates, and strategic growth in biosciences. However, it also faced significant challenges such as weather disruptions, production issues, and financial impacts in Brazil, leading to a mixed outlook.

Company Guidance

During the third quarter of 2024 earnings call for The Mosaic Company, several key metrics and operational insights were shared. Despite challenges such as hurricanes and electrical issues at potash mines, Mosaic reported $2.8 billion in revenue, with a net income of $122 million and an adjusted EBITDA of $448 million. The company aims to reach an annual phosphate production run rate of 7.8 to 8.2 million tons by year-end. They are also on track to achieve $150 million in annual cost savings by the end of 2025 and a $200 million reduction in capital expenditures for the current year. In terms of market outlook, Mosaic anticipates strong fertilizer demand in 2025 due to nutrient replenishment needs. Potash prices are expected to stabilize, with sales volumes projected between 2.2 to 2.4 million tons in Q4 at prices of $200 to $220 per ton. Phosphate sales for the fourth quarter are expected to be between 1.6 to 1.8 million tons, with prices ranging from $570 to $590 per ton. Additionally, Mosaic Biosciences is expanding, with biological products now used on 9 million acres globally.

Quick Recovery from Hurricanes

Mosaic's operations in Florida were back at full operating rates just two weeks after Hurricane Milton, with some locations returning to normal within days.

Phosphate Production and Cost Management

Mosaic expects to achieve its targeted annualized phosphate production run rate of 7.8 million to 8.2 million tons by year-end and is on track to achieve a $150 million annual run rate cost savings target by the end of 2025.

Strong Stripping Margin in Phosphates

The Phosphates segment generated adjusted EBITDA of $265 million, an improvement from $201 million a year ago, due to solid pre-hurricane production levels and strong stripping margins.

Mosaic Biosciences Growth

Mosaic Biosciences' growth is accelerating with biological products being used on 9 million acres worldwide, supported by new product launches and partnerships.

Capital Allocation and Shareholder Returns

Mosaic returned $415 million to shareholders during the first nine months of 2024, including $210 million of share repurchases.

---

Mosaic Co (MOS) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

MOS Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Feb 19, 2025	2024 (Q4)	0.61 / -	0.71	―	―	―
Nov 12, 2024	2024 (Q3)	0.52 / 0.34	0.68	-50.00% (-0.34)
Aug 06, 2024	2024 (Q2)	0.66 / 0.54	1.04	-48.08% (-0.50)
May 01, 2024	2024 (Q1)	0.66 / 0.65	1.14	-42.98% (-0.49)
Feb 21, 2024	2023 (Q4)	0.87 / 0.71	1.74	-59.20% (-1.03)
Nov 07, 2023	2023 (Q3)	0.75 / 0.68	3.22	-78.88% (-2.54)
Aug 01, 2023	2023 (Q2)	1.09 / 1.04	3.64	-71.43% (-2.60)
May 03, 2023	2023 (Q1)	1.24 / 1.14	2.41	-52.70% (-1.27)
Feb 22, 2023	2022 (Q4)	2.13 / 1.74	1.95	-10.77% (-0.21)
Nov 07, 2022	2022 (Q3)	3.34 / 3.22	1.35	138.52% (+1.87)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

---

MOS Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Nov 12, 2024	$27.81	$25.66	-7.73%
Aug 06, 2024	$26.57	$26.19	-1.43%
May 01, 2024	$29.25	$27.77	-5.06%
Feb 21, 2024	$29.35	$31.28	+6.58%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

---